Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer
Claudia Marchetti, Francesca De Felice, Anna Di Pinto, Alessia Romito, Angela Musella, Innocenza Palaia, Marco Monti, Vincenzo Tombolin, Ludovico Muzii, PierLuigi Benedetti Panici
Cancer Res Treat. 2018;50(3):768-776.   Published online 2017 Jul 19     DOI: https://doi.org/10.4143/crt.2017.141
Citations to this article as recorded by Crossref logo
Pembrolizumab for advanced cervical cancer: safety and efficacy
Francesca De Felice, Elena Giudice, Giulia Bolomini, Maria Grazia Distefano, Giovanni Scambia, Anna Fagotti, Claudia Marchetti
Expert Review of Anticancer Therapy.2021; 21(2): 221.     CrossRef
Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors
Xiaomin Zheng, Weiqian Guo, Jiangning Dong, Liting Qian
Magnetic Resonance Imaging.2020; 72: 159.     CrossRef
Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study
Guilan Xie, Ruiqi Wang, Li Shang, Cuifang Qi, Liren Yang, Liyan Huang, Wenfang Yang, Mei Chun Chung
BMC Cancer.2020;[Epub]     CrossRef
SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines
Xing Chen, Dongsheng Xiong, Liya Ye, Huichun Yang, Shuangshuang Mei, Jinhong Wu, Shanshan Chen, Ruoran Mi
Cancer Chemotherapy and Pharmacology.2019; 83(4): 603.     CrossRef
Systemic therapy in cervical cancer: 30 years in review
Michalis Liontos, Anastasios Kyriazoglou, Ioannis Dimitriadis, Meletios-Athanasios Dimopoulos, Aristotelis Bamias
Critical Reviews in Oncology/Hematology.2019; 137: 9.     CrossRef
Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis
Meng Li, Mengyang Hu, Yuanjian Wang, Xingsheng Yang
European Journal of Obstetrics & Gynecology and Reproductive Biology.2019; 238: 1.     CrossRef
Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study
Lei Li, Ming Wu, Shuiqing Ma, Xianjie Tan, Sen Zhong
International Journal of Clinical Oncology.2019; 24(11): 1440.     CrossRef
Immune check-point in cervical cancer
F. De Felice, C. Marchetti, I. Palaia, R. Ostuni, L. Muzii, V. Tombolini, P. Benedetti Panici
Critical Reviews in Oncology/Hematology.2018; 129: 40.     CrossRef